Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Milton EssexWAR:MTN -1.36%29 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates WAR:MTN with a GF Score™ of 29/100 and a GF Value™ of zł0.13 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Milton Essex ranks worse than 99.76% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Milton Essex's Net Income for the
three
months ended in Mar. 2026 was zł-0.16 Mil. Milton Essex's Revenue for the
three
months ended in Mar. 2026 was zł0.00 Mil. Therefore, Milton Essex's net margin for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for Milton Essex's Net Margin % or its related term are showing as below:
WAR:MTN'
s Net Margin % Range Over the Past 10 Years
Min: -120700 Med: -3486.67 Max: 24.12
Current: -80100
WAR:MTN's Net Margin % is ranked worse than 99.76% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 2.045
vs WAR:MTN: -80100.00
Milton Essex (WAR:MTN) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Milton Essex Net Margin % Related Terms
Milton Essex Net Margin % Historical Data
* Premium members only.
The historical data trend for Milton Essex's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Milton Essex's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Milton Essex Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Milton Essex's Net Margin % distribution charts can be found below:
* The bar in red indicates where Milton Essex's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Milton Essex (WAR:MTN) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Milton Essex and its competitors. According to the industry distribution chart, Milton Essex ranks #816 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 99.8%.
Is Milton Essex's Net Margin % too high?
Milton Essex's current Net Margin % is 0.00%. Based on the distribution chart, Milton Essex ranks #816 out of 818 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Milton Essex has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Milton Essex's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Milton Essex ranks #816 out of 818 companies for Net Margin %. This places Milton Essex in the lower half of its industry. The industry median Net Margin % is 2.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.05, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Milton Essex and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Milton Essex's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milton Essex stock overvalued right now?
Based on GuruFocus' analysis, Milton Essex (WAR:MTN) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.13, compared to a current price of zł0.73 — trading 457.7% above its estimated fair value. The current Net Margin % is 0.00%. Milton Essex's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Milton Essex (WAR:MTN), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Milton Essex (WAR:MTN) Overvalued in 2026?
Based on GuruFocus' analysis, Milton Essex stock appears to be overvalued.
The current stock price of zł0.73 is trading 457.7% above its estimated GF Value™ of zł0.13.
GuruFocus considers Milton Essex to be Significantly Overvalued.
Key valuation signals for WAR:MTN:
Net Margin %: 0.00%
GF Value™: zł0.13 vs. price of zł0.73 (457.7% above fair value)
No single metric tells the full story. See the WAR:MTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Milton Essex SA provides contact-free hybrid scanners for allergology and oncological dermatology. The products of the company include Ski Sense, FaceCov and InfraSkin.
29GF Score
Get the complete analysis for WAR:MTN
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:MTN has been successfully added to your 
